Study of the Absorption, Metabolism, and Excretion of [14C]-Ecopipam in Healthy Male Subjects
Clinical trial NCT04881955 · COMPLETED
Trial details
- NCT number
- NCT04881955
- Sponsor
- Emalex Biosciences Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-12
- Primary completion
- 2021-09-07
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.